Multigenic lentiviral vectors for combined and tissue-specific expression of miRNA- and protein-based antiangiogenic factors

Molecular Therapy Methods and Clinical Development

Volumn 2, Issue , 2015, Pages 14064-

  Askou, Anne Louise ^a   Aagaard, Lars ^a   Kostic, Corinne ^b   Arsenijevic, Yvan ^b   Hollensen, Anne Kruse ^a   Bek, Toke ^c   Jensen, Thomas Gryesten ^a   Mikkelsen, Jacob Giehm ^a   Corydon, Thomas Juhl ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; LENTIVIRUS VECTOR; MICRORNA; PIGMENT EPITHELIUM DERIVED FACTOR; VASCULOTROPIN; SHORT HAIRPIN RNA; SMALL NUCLEAR RNA; VASCULOTROPIN ANTIBODY;

ADULT; AGE RELATED MACULAR DEGENERATION; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC GENE THERAPY; ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; INTRON; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RETINAL PIGMENT EPITHELIUM; TARGET CELL; TRANSGENE; ANIMAL CELL; ANTIANGIOGENIC ACTIVITY; EMBRYO; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VITELLIFORM MACULAR DEGENERATION; WESTERN BLOTTING;

EID: 84939831346     PISSN: None     EISSN: 23290501     Source Type: Journal    
DOI: 10.1038/mtm.2014.64     Document Type: Article

References (40)

1. 1 Tozer, K, Roller, AB, Chong, LP, Sadda, S, Folk, JC, Mahajan, VB, et al. Combination therapy for neovascular age-related macular degeneration refractory to anti-vascular endothelial growth factor agents. Ophthalmology 120 (2013), 2029–2034.
2. 2 Singerman, L, Combination therapy using the small interfering RNA bevasiranib. Retina (Philadelphia, Pa) 29:6 Suppl (2009), S49–S50.
3. 3 Augustin, AJ, Puls, S, Offermann, I, Triple therapy for choroidal neovascularization due to age-related macular degeneration: verteporfin PDT, bevacizumab, and dexamethasone. Retina (Philadelphia, Pa) 27 (2007), 133–140.
4. 4 Reich, SJ, Fosnot, J, Kuroki, A, Tang, W, Yang, X, Maguire, AM, et al. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model. Mol Vis 9 (2003), 210–216.
5. 5 Kaiser, PK, Symons, RC, Shah, SM, Quinlan, EJ, Tabandeh, H, Do, DV, et al., Sirna-027 Study Investigators. RNAi-based treatment for neovascular age-related macular degeneration by Sirna-027. Am J Ophthalmol 150 (2010), 33–39.e2.
6. 6 Nguyen, QD, Schachar, RA, Nduaka, CI, Sperling, M, Basile, AS, Klamerus, KJ, et al., PF-04523655 Study Group. Phase 1 dose-escalation study of a siRNA targeting the RTP801 gene in age-related macular degeneration patients. Eye (Lond) 26 (2012), 1099–1105.
7. 7 Garba, AO, Mousa, SA, Bevasiranib for the treatment of wet, age-related macular degeneration. Ophthalmol Eye Dis 2 (2010), 75–83.
8. 8 Nguyen, QD, Schachar, RA, Nduaka, CI, Sperling, M, Klamerus, KJ, Chi-Burris, K, et al., MONET Clinical Study Group. Evaluation of the siRNA PF-04523655 versus ranibizumab for the treatment of neovascular age-related macular degeneration (MONET Study). Ophthalmology 119 (2012), 1867–1873.
9. 9 Kleinman, ME, Yamada, K, Takeda, A, Chandrasekaran, V, Nozaki, M, Baffi, JZ, et al. Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature 452 (2008), 591–597.
10. 10 Cashman, SM, Bowman, L, Christofferson, J, Kumar-Singh, R, Inhibition of choroidal neovascularization by adenovirus-mediated delivery of short hairpin RNAs targeting VEGF as a potential therapy for AMD. Invest Ophthalmol Vis Sci 47 (2006), 3496–3504.
11. 11 Askou, AL, Pournaras, JA, Pihlmann, M, Svalgaard, JD, Arsenijevic, Y, Kostic, C, et al. Reduction of choroidal neovascularization in mice by adeno-associated virus-delivered anti-vascular endothelial growth factor short hairpin RNA. J Gene Med 14 (2012), 632–641.
12. 12 Pihlmann, M, Askou, AL, Aagaard, L, Bruun, GH, Svalgaard, JD, Holm-Nielsen, MH, et al. Adeno-associated virus-delivered polycistronic microRNA-clusters for knockdown of vascular endothelial growth factor in vivo. J Gene Med 14 (2012), 328–338.
13. 13 Corydon, TJ, Haagerup, A, Jensen, TG, Binderup, HG, Petersen, MS, Kaltoft, K, et al. A functional CD86 polymorphism associated with asthma and related allergic disorders. J Med Genet 44 (2007), 509–515.
14. 14 Masuda, T, Esumi, N, SOX9, through interaction with microphthalmia-associated transcription factor (MITF) and OTX2, regulates BEST1 expression in the retinal pigment epithelium. J Biol Chem 285 (2010), 26933–26944.
15. 15 Aagaard, LA, Zhang, J, von Eije, KJ, Li, H, Saetrom, P, Amarzguioui, M, et al. Engineering and optimization of the miR-106b cluster for ectopic expression of multiplexed anti-HIV RNAs. Gene Ther 15 (2008), 1536–1549.
16. 16 Bainbridge, JW, Smith, AJ, Barker, SS, Robbie, S, Henderson, R, Balaggan, K, et al. Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med 358 (2008), 2231–2239.
17. 17 Maguire, AM, Simonelli, F, Pierce, EA, Pugh, EN Jr, Mingozzi, F, Bennicelli, J, et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med 358 (2008), 2240–2248.
18. 18 Hauswirth, WW, Aleman, TS, Kaushal, S, Cideciyan, AV, Schwartz, SB, Wang, L, et al. Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial. Hum Gene Ther 19 (2008), 979–990.
19. 19 Campochiaro, PA, Nguyen, QD, Shah, SM, Klein, ML, Holz, E, Frank, RN, et al. Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a phase I clinical trial. Hum Gene Ther 17 (2006), 167–176.
20. 20 Lai, CM, Shen, WY, Brankov, M, Lai, YK, Barnett, NL, Lee, SY, et al. Long-term evaluation of AAV-mediated sFlt-1 gene therapy for ocular neovascularization in mice and monkeys. Mol Ther 12 (2005), 659–668.
21. 21 Maclachlan, TK, Lukason, M, Collins, M, Munger, R, Isenberger, E, Rogers, C, et al. Preclinical safety evaluation of AAV2-sFLT01- a gene therapy for age-related macular degeneration. Mol Ther 19 (2011), 326–334.
22. 22 Binley, K, Widdowson, PS, Kelleher, M, de Belin, J, Loader, J, Ferrige, G, et al. Safety and biodistribution of an equine infectious anemia virus-based gene therapy, RetinoStat(®), for age-related macular degeneration. Hum Gene Ther 23 (2012), 980–991.
23. 23 ter Brake, O, ‘t Hooft, K, Liu, YP, Centlivre, M, von Eije, KJ, Berkhout, B, Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition. Mol Ther 16 (2008), 557–564.
24. 24 Castanotto, D, Sakurai, K, Lingeman, R, Li, H, Shively, L, Aagaard, L, et al. Combinatorial delivery of small interfering RNAs reduces RNAi efficacy by selective incorporation into RISC. Nucleic Acids Res 35 (2007), 5154–5164.
25. 25 Grimm, D, Streetz, KL, Jopling, CL, Storm, TA, Pandey, K, Davis, CR, et al. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 441 (2006), 537–541.
26. 26 Martin, JN, Wolken, N, Brown, T, Dauer, WT, Ehrlich, ME, Gonzalez-Alegre, P, Lethal toxicity caused by expression of shRNA in the mouse striatum: implications for therapeutic design. Gene Ther 18 (2011), 666–673.
27. 27 Maetzig, T, Galla, M, Brugman, MH, Loew, R, Baum, C, Schambach, A, Mechanisms controlling titer and expression of bidirectional lentiviral and gammaretroviral vectors. Gene Ther 17 (2010), 400–411.
28. 28 Kliffen, M, Sharma, HS, Mooy, CM, Kerkvliet, S, de Jong, PT, Increased expression of angiogenic growth factors in age-related maculopathy. Br J Ophthalmol 81 (1997), 154–162.
29. 29 Esumi, N, Oshima, Y, Li, Y, Campochiaro, PA, Zack, DJ, Analysis of the VMD2 promoter and implication of E-box binding factors in its regulation. J Biol Chem 279 (2004), 19064–19073.
30. 30 Kachi, S, Binley, K, Yokoi, K, Umeda, N, Akiyama, H, Muramatu, D, et al. Equine infectious anemia viral vector-mediated codelivery of endostatin and angiostatin driven by retinal pigmented epithelium-specific VMD2 promoter inhibits choroidal neovascularization. Hum Gene Ther 20 (2009), 31–39.
31. 31 Cai, Y, Bak, RO, Krogh, LB, Staunstrup, NH, Moldt, B, Corydon, TJ, et al. DNA transposition by protein transduction of the piggyBac transposase from lentiviral Gag precursors. Nucleic Acids Res, 42, 2014, e28.
32. 32 Aparicio, S, Sawant, S, Lara, N, Barnstable, CJ, Tombran-Tink, J, Expression of angiogenesis factors in human umbilical vein endothelial cells and their regulation by PEDF. Biochem Biophys Res Commun 326 (2005), 387–394.
33. 33 Kitamura, T, Asai, N, Enomoto, A, Maeda, K, Kato, T, Ishida, M, et al. Regulation of VEGF-mediated angiogenesis by the Akt/PKB substrate Girdin. Nat Cell Biol 10 (2008), 329–337.
34. 34 Hassel, D, Cheng, P, White, MP, Ivey, KN, Kroll, J, Augustin, HG, et al. MicroRNA-10 regulates the angiogenic behavior of zebrafish and human endothelial cells by promoting vascular endothelial growth factor signaling. Circ Res 111 (2012), 1421–1433.
35. 35 Bai, YJ, Huang, LZ, Xu, XL, Du, W, Zhou, AY, Yu, WZ, et al. Polyethylene glycol-modified pigment epithelial-derived factor: new prospects for treatment of retinal neovascularization. J Pharmacol Exp Ther 342 (2012), 131–139.
36. 36 Okamoto, S, Amaishi, Y, Goto, Y, Ikeda, H, Fujiwara, H, Kuzushima, K, et al. A Promising Vector for TCR Gene Therapy: Differential Effect of siRNA, 2A Peptide, and Disulfide Bond on the Introduced TCR Expression. Mol Ther Nucleic Acids, 1, 2012, e63.
37. 37 Yáñez-Muñoz, RJ, Balaggan, KS, MacNeil, A, Howe, SJ, Schmidt, M, Smith, AJ, et al. Effective gene therapy with nonintegrating lentiviral vectors. Nat Med 12 (2006), 348–353.
38. 38 Jakobsen, M, Stenderup, K, Rosada, C, Moldt, B, Kamp, S, Dam, TN, et al. Amelioration of psoriasis by anti-TNF-alpha RNAi in the xenograft transplantation model. Mol Ther 17 (2009), 1743–1753.
39. 39 Corydon, TJ, Bross, P, Holst, HU, Neve, S, Kristiansen, K, Gregersen, N, et al. A human homologue of Escherichia coli ClpP caseinolytic protease: recombinant expression, intracellular processing and subcellular localization. Biochem J 331 (Pt 1) (1998), 309–316.
40. 40 Corydon, TJ, Hansen, J, Bross, P, Jensen, TG, Down-regulation of Hsp60 expression by RNAi impairs folding of medium-chain acyl-CoA dehydrogenase wild-type and disease-associated proteins. Mol Genet Metab 85 (2005), 260–270.